Romidepsin enhances the efficacy of cytarabine in vivo, revealing histone deacetylase inhibition as a promising therapeutic strategy for KMT2A-rearranged infant acute lymphoblastic leukemia

HAEMATOLOGICA

FERRATA STORTI FOUNDATION

1. Children's Leukaemia and Cancer Research Foundation, Western Australia
2. Telethon-Perth Children's Hospital Research Fund, Western Australia
3. Royal Australasian College of Physicians (RACP)/The Kids Cancer Project Research Establishment Fellowship
4. Woolworths Children's Leukaemia and Cancer Research Foundation Fellowship
5. Kids' Cancer Project, New South Wales
6. National Health and Medical Research Council of Australia [NHMRC APP1059804, NHMRC- APP1142627]